Molecular Pharmacology
A section of Current Issues in Molecular Biology (ISSN 1467-3045).
Section Information
The ‘Molecular Pharmacology’ section of the journal Current Issues in Molecular Biology (CIMB) publishes original research articles and reviews of the highest quality on the subject of drug discovery and therapeutics at the molecular level. The journal covers a range of relevant topics, including computational drug design and the prediction of drug targets, together with experimental testing of the model; the identification of novel potential therapeutic targets at the molecular level; studies on drug delivery; analyses of the impact of drugs on cellular signaling pathways; and drug metabolism.
The subtopics covered include, but are not limited to, the following:
- Examination of drug–receptor interactions through various methodologies;
- Advances in pharmacotherapeutic strategies against human diseases;
- New molecular targets of already known drugs ("old players");
- Neuro- and cardiopharmacology;
- Systems analysis of drug action;
- Pharmacogenomics;
- New candidates for the fight against cancer.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Network Pharmacology, Multi-targets and Receptor–Receptor Interactions in the CNS (Deadline: 30 September 2024)
- Advances in Pharmacotherapeutic Strategies to Prevent Tumor Development, Progression and Treatment Resistance (Deadline: 30 November 2024)
- Molecular Biology in Drug Design and Precision Therapy (Deadline: 31 December 2024)
- Neuropharmacology and Brain Physiology: From Molecular Mechanisms to Medicines Application (Deadline: 31 January 2025)
- Editorial Board Members' Collection Series: Natural Product Pharmacology (Deadline: 25 February 2025)
